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One of the herpes simplex virus envelope glycoproteins, designated gD, is the principal determinant of cell recognition for viral entry. Other
viral glycoproteins, gB, gH and gL, cooperate with gD to mediate the membrane fusion that is required for viral entry and cell fusion. Membrane
fusion is triggered by the binding of gD to one of its receptors. These receptors belong to three different classes of cell surface molecules. This
review summarizes recent findings on the structure and function of gD. The results presented indicate that gD may assume more than one
conformation, one in the absence of receptor, another when gD is bound to the herpesvirus entry mediator, a member of the TNF receptor family,
and a third when gD is bound to nectin-1, a cell adhesion molecule in the immunoglobulin superfamily. Finally, information and ideas are
presented about a membrane-proximal region of gD that is required for membrane fusion, but not for receptor binding, and that may have a role in
activating the fusogenic activity of gB, gH and gL.
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Myscofski/202-772-9575, Washington, DC 20528, USA.HSV disease and gD as a determinant of cell recognition for
entry
Herpes simplex viruses types 1 and 2 (serotypes HSV-1 and
HSV-2) infect a majority of persons in most human popula-
tions. Symptoms of disease are not always apparent, even
during primary infection. Disease symptoms can range from
mucocutaneous lesions to life-threatening encephalitis or06) 17 – 24
www.e
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sion of infection from person to person is usually by intimate
contact and sharing of body fluids containing virus. This virus
can initiate infection by invading epithelial cells of the oral or
genital mucosa, the cornea or skin at any location, provided the
cornified layer has been disrupted. HSV replicates in the
epithelium, destroying the cells and causing vesicular lesions.
Virus also enters the endings of neurons that enervate the
region, resulting in movement of virus to neuronal cell bodies
in sensory and autonomic ganglia, where latent infections are
established. Latent reservoirs of viral genomes cannot be
eliminated by the immune system or current antiviral therapy,
guaranteeing the infected person a life-long relationship with
HSV. This relationship may be uneventful or may be
characterized by sporadic or periodic reactivation of virus with
recurrence of mucocutaneous lesions or, rarely, by movement
of virus to the central nervous system to cause encephalitis.
Cellular targets of HSV include, but are not limited to,
epithelial cells of skin and mucosa, neurons and cells of the
immune system. This virus is capable of infecting other
differentiated cell types, however, as is evident from dissemi-
nated disease that can occur in neonates and in immunocom-
promised individuals. Also, although the only natural hosts for
HSVare humans, a variety of laboratory animals can be infected
by this virus. Moreover, cultured cells from a variety of tissues
and vertebrate species are susceptible to HSV infection. Thus,
the virus has a broad host range with respect to viral entry even
though not all infected cells can support a productive viral
replicative cycle.
The virion component that engages in specific interactions
with cell surface receptors and determines whether the cell can
be infected is principally the envelope glycoprotein gD. Even
though many cultured cell types express one or more of the
receptors that can be recognized by gD, cells in certain
organized tissues may not express such receptors or the
receptors may not be accessible to HSV, accounting perhaps
in part for the relatively localized nature of HSV infection and
spread in normal immunocompetent adults. The purpose of this
review is to summarize recent progress in defining the structure
of gD; multiple conformations of gD; interfaces on gD for
multiple cell surface receptors, any one of which can mediate
viral entry; and the effects of mutations in gD on receptor
usage, viral glycoprotein-induced cell fusion and viral entry.
Overview of HSV entry
The HSV virion is composed of a DNA genome of about 150
kbp, a capsid shell with 162 capsomers, a protein layer termed
the tegument on the outside of the capsid shell and an outer
limiting membrane or envelope composed of viral membrane
proteins and glycoproteins embedded in a lipid bilayer. The
initial interaction of HSV with the cell surface is usually binding
to heparan sulfate (reviewed by Shukla and Spear, 2001), at least
in the case of most cell types cultured in monolayer. This binding
can be mediated by envelope glycoprotein gB or gC, serves to
concentrate the virus on the cell surface and significantly
enhances the efficiency of viral entry. This binding, however,is a reversible step and is not strictly required for viral entry.
Entry depends on the binding of gD to one of its cell surface
receptors, which include HVEM (herpesvirus entry mediator), a
member of the tumor necrosis factor receptor family; nectin-1 or
nectin-2, cell adhesion molecules belonging to the immuno-
globulin (Ig) superfamily; and specific modifications in heparan
sulfate (3-O-S HS) catalyzed by particular isoforms of 3-O-
sulfotransferase (reviewed by Spear et al., 2000).
A cDNA encoding another potential HSVentry receptor was
identified on the basis of ability of its expressed protein to
make resistant cells more susceptible to viral entry (Perez et al.,
2005). The protein, designated B5, is similar to dendritic cell
protein and has motifs characteristic of proteosome subunits.
Tagged versions of this unusual and highly conserved protein
have been detected on the cell surface, but reagents were not
available to determine whether the untagged version was
expressed on the cell surface. It has not yet been shown that B5
interacts directly with HSV virions or with a virion glycopro-
tein. Since there is no evidence that B5 interacts with gD, it will
not be considered further in this review.
Entry occurs by fusion of the HSV envelope with the cell
plasma membrane or membrane of an endosome and depends
on the action of three other viral envelope glycoproteins,
designated gB, gH and gL, in addition to gD and a gD receptor.
The current thinking is that binding of gD to one of its
receptors causes conformational changes in gD that permit
recruitment of gB, a homotrimer, and gH–gL, a heterodimer,
and activation of their membrane-fusing activity.
The actual viral fusogen has not been identified but is thought
not to be gD, for several reasons. First, although gB, gH and gL
are conserved among herpesviruses and thought to constitute the
basic membrane-fusing machinery, members of the gD family
are encoded only by one subfamily of the herpesviruses, the
alphaherpesviridae. Second, most viral fusogens are not
functional unless anchored in the membrane of the virion
envelope or cell surface; changes in conformation that expose
another hydrophobic domain, a fusion peptide, then enable its
insertion into a target membrane (reviewed by Earp et al., 2004).
By contrast, truncated soluble ectodomains or glycosylpho-
sphatidylinositol-linked forms of gD can restore entry activity to
gD-negative virions (Cocchi et al., 2004) or trigger cell fusion
(Jones and Geraghty, 2004), respectively. Moreover, no domain
resembling a fusion peptide has been identified in gD.
The findings presented here about HSV gD may apply to
other members of the alphaherpesviridae, a subfamily that
includes human and animal neurotropic herpesviruses. Most
members of the alphaherpesviridae (a notable exception being
varicella zoster virus), but not herpesviruses belonging to the
beta- or gamma-subfamilies, encode a member of the gD
family. Ability of alphaherpesvirus gDs to engage members of
the nectin family as entry receptors appears to be characteristic
of viruses from a variety of mammalian species. The broad host
ranges of many alphaherpesviruses, at least for viral entry, can
be attributed to the fact that they can engage heparan sulfate, a
ubiquitous cell surface component, for binding to cells, and
members of the nectin family for viral entry (Mettenleiter,
2000; Spear and Longnecker, 2003). The nectin family consists
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evolutionarily related and have ectodomains consisting of three
Ig-like folds (one V-like and two C-like) (reviewed by
Nakanishi and Takai, 2004). Certain nectins, such as nectin-
1, are highly conserved in amino acid sequence among
mammalian species (Milne et al., 2001; Shukla et al., 2000).
HSV-1 and HSV-2 gDs exhibit 82% identity in amino acid
sequence and are believed to be similar both structurally and
functionally. The limited divergence in amino acid sequence,
however, determines differences between HSV-1 and HSV-2 in
receptor preferences. Both HVEM and nectin-1 are active as
entry receptors for HSV-1 and HSV-2, whereas nectin-2
mediates entry of HSV-2 selectively, and 3-O-H HS mediates
entry of HSV-1 selectively. This review will focus principally
on the interactions of HSV-1 gD with nectin-1 and HVEM and
will include available data on its interactions with 3-O-S HS.
The more limited information about HSV-2 gD will be
presented as available.
Structure of gD and alternative conformations
HSV-1 gD, a type 1 glycoprotein, is translated as a 394-
amino acid (aa) polypeptide, from which a 25-aa N-terminal
signal sequence is removed by signal peptidase cleavage. The
ectodomain of the mature glycoprotein is 316 aa, with a
membrane-spanning domain predicted to be about 23 aa and a
cytoplasmic tail of 30 aa. Three N-linked glycans are added to
the ectodomain as well as O-linked glycans. HSV-2 gD is
shorter in the ectodomain by 1 aa but otherwise has all the
features just described for HSV-1 gD.
X-ray structures of HSV-1 gDwere obtained using crystals of
a truncated form of the gD ectodomain (first 285 aa) and co-
crystals of this truncated form of gD with a truncated form of
HVEM (first 162 aa) (Carfi et al., 2001). Both structures
revealed that a major portion of the gD ectodomain forms an Ig-
like fold with N-terminal and C-terminal extensions. In the co-
crystal with HVEM, the first 259 aa of gD could be resolved, and
the N-terminus formed a hairpin in which were all the contacts
with HVEM, within the region encompassed by aa 7–15 and
24–32 (Figs. 1A and C). In the crystals of gD alone, aa 14 to 255
were resolved, and the portion of the N-terminus that could be
resolved was extended (Figs. 1B and D). In both structures, part
of the region downstream of the Ig-like fold (aa 224–240)
formed an extended a-helix. This a-helix occupies a position
between the Ig fold and N-terminal hairpin in the gD–HVEM
complex.
Since these structures provided no information about the
membrane-proximal 50–60 aa of the ectomain, X-ray analysis
was performed on crystals obtained from a longer truncated form
of gD encompassing aa 1–306, with a cysteine added at position
307 to promote dimerization (C. Krummenacher, M. Supekar,
J.C. Whitbeck, E. Lazear, S.A. Connolly, G.H. Cohen, R.J.
Eisenberg, D.C. Wiley, and A. Carfi, 2005, Structural model of
receptor-mediated activation of HSV fusion, Abstract 2.9, 30th
International Herpesvirus Workshop, Turku, Finland, and
personal communication from the authors). The structure
resolved was a disulfide-linked dimer missing the first 22 aadue to spontaneous cleavage during crystallization. In this
structure, the N-terminus and C-terminus were in contact, with
P291 and the side chain of W294 protruding into a pocket
formed partially of residues 25–27. Hydrophobic interactions
were likely important, but hydrogen bonds were evident also,
between the Q27 side chain and the H295 backbone and the
W294 and N293 side chains with the L25 backbone.
Several other lines of evidence also indicate the existence of
N-terminal/C-terminal interactions within the ectodomain of
gD, at least in the absence of receptor binding. First, amino
acid substitutions at positions 25 or 27 or deletions encom-
passing aa 290–300 destroy the epitope of a conformational-
dependent monoclonal antibody AP7 but not those of other
conformation-dependent antibodies (Brandimarti et al., 1994;
Chiang et al., 1994; Dean et al., 1994; Minson et al., 1986).
Second, soluble forms of gD truncated after aa 250, 260 or 285
bind to HVEM and nectin-1 with affinities 100-fold higher than
that characteristic of gD truncated at aa 306 (Whitbeck et al.,
1999). This demonstrates that the receptor-binding domains are
contained within aa 1–250 and also suggests that a region
between aa 285 and 306 has a negative influence on
accessibility of the upstream receptor-binding domains. Third,
GST–fusion proteins containing regions of gD encompassing
aa 260–310 (particularly region 285–310) were shown to bind
to soluble forms of gD truncated after aa 260, 275, 285 or 290.
Interestingly, this binding was not observed in the presence of
soluble HVEM or nectin-1 or to soluble gD truncated after aa
306. These results indicate that the membrane-proximal region
of the gD ectodomain interacts with a region within 1–260 aa
and suggests that this interaction is prevented by the binding of
either receptor to gD (Fusco et al., 2005). Current thinking is
that gD can assume multiple conformations, at least one in the
absence of receptor and, as will be argued below, at least two
others when either HVEM or nectin-1 is bound.
Mutations that abrogate interactions of gD with HVEM
Extensive mutagenic analysis of HSV-1 gD has been
performed (Table 1 and Fig. 1). It has been possible to identify
amino acid substitutions, insertions and deletions that abrogate
physical and functional interactions of gD with HVEM (and 3-
O-S HS) but are without effect on interactions with nectin-1.
All of these mutations are located in the contact region with
HVEM determined from the X-ray structure, except for three
substitutions as described below. The results may be summa-
rized as follows. (i) Substitutions of amino acids that make
direct contact with HVEM, according to the X-ray structure,
revealed that three (Q27A, T29A and D30A) of the fourteen
mutations abrogated binding of gD to HVEM, as well as cell
fusion and viral entry mediated by HVEM. Another four
mutations (M11A, N15A, L25A and L28A) impaired binding
to HVEM but only partially reduced cell fusion and viral entry
activity (Connolly et al., 2003). (ii) Random mutagenesis of
HSV-1 gD identified additional substitutions and a deletion that
abrogated viral entry via HVEM (M11P, P14R, D30P, G43P,
Q27P, L28G, L28P, D28, T29P) or reduced entry via HVEM
(N15E, D26R, L28R, Q132P, K190P) but were without effect
Fig. 1. Residues in gD that are critical for binding to HVEM (A and C) and to nectin-1 (B and D). The structures shown are those determined for gD in complex
with HVEM (A and C) or for gD alone (B and D). Panels A and B show the two different structures in the same orientation, whereas panels C and D an
orientation different from that of panels A and B, to enable visualization of all the critical residues for interactions with each receptor. HVEM is not shown in
panels A and C, but the backbone of the contact regions with HVEM is colored green. At the positions of critical residues, the side chains are shown in ball and
chain format and colored orange. Beta strands are colored purple and alpha-helices yellow. The structures shown are based on the coordinates deposited in the
Protein Data Bank (Berman et al., 2000) for entries 1JMA and 1L2G (Carfi et al., 2001). Molecular graphics images were produced by using the UCSF
CHIMERA package (Huang et al., 1996) from the Computer Graphics Laboratory, University of California, San Francisco (supported by National Institutes of
Health Grant P41 RR-01081).
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radical amino acid substitutions, identified additional residues
in the contact regions that are critical for functional interactionsNotes to Table 1:
a
Binding of mutant forms of gD to receptor was assessed by quantification of the
binding of solubilized full-length gD to soluble receptors immobilized on ELISA p
b
Cell fusion assays were performed by transfecting cells with plasmids expressin
(effector cells) and mixing them with cells expressing the receptor indicated and tr
promoter (target cells) and then quantifying luciferase expression.
c
Viral entry assays were performed using gD-negative viral mutants that had been
assays) or using HSV-1 strains expressing the mutant form of gD.
d
1—Connolly et al. (2003); 2—Connolly et al. (2005); 3—Manoj et al. (2004
(1996).
e
wt = 80–120% of wild-type values; jj = >200% of wild type; j = 120–200%
detectable activity, n.d. = not done.of gD with HVEM. This approach also identified three
mutations outside the known contact regions (G43P, Q132P
and K190P) that impaired functional interactions with HVEMbinding of gD:Fc hybrid proteins to cells expressing the receptors indicated or
lates.
g T7 polymerase and HSV-1 gB, gH, gL and mutant or wild-type forms of gD
ansfected with a plasmid carrying the luciferase gene under control of the T7
passed once through cells expressing the mutant form of gD (complementation
); 4—Yoon et al. (2003); 5—Yoon and Spear (2004); 6—Montgomery et al.
of wild type; , = 50–80% of wild type; ,, = <50% of wild type; – = no
Table 1
Mutations in HSV-1 gD and effects on binding to, fusion with, and viral entry via the receptors indicated
Mutations in HSV-1 gD Nectin-1 HVEM 3-O-S HS Citationsd
Bindinga Cell fusionb Viral entryc Binding Cell fusion Viral entry Binding Cell fusion Viral entry
D7–21 wte wt n.d. – – n.d. n.d. ,, n.d. 4
D7–15 wt wt n.d. – – n.d. n.d. ,, n.d. 4
D24–32 wt wt n.d. – – n.d. n.d. ,, n.d. 4
D7–15/24–32 wt wt n.d. – – n.d. n.d. ,, n.d. 4
D7–32 wt wt jj – – – n.d. ,, n.d. 3, 4
A7V wt j j , wt j n.d. n.d. n.d. 1
M11A j wt wt – ,, , n.d. n.d. n.d. 1
M11P n.d. n.d. wt n.d. n.d. – n.d. n.d. ,, 5
A12V wt wt j j j j n.d. n.d. n.d. 1
P14A j wt wt wt wt , n.d. n.d. n.d. 1
P14R n.d. n.d. wt n.d. n.d. – n.d. n.d. ,, 5
N15A wt wt j ,, ,, , n.d. n.d. n.d. 1
N15E n.d. n.d. wt n.d. n.d. , n.d. n.d. ,, 5
V24A j wt wt wt , j n.d. n.d. n.d. 1
L25A j wt wt – ,, ,, n.d. n.d. n.d. 1
L25P j wt wt , wt ,, n.d. ,, n.d. 4
D26A wt wt n.d. , , wt n.d. n.d. n.d. 1
D26R n.d. n.d. wt n.d. n.d. ,, n.d. n.d. – 5
Q27A jj wt wt – – – n.d. n.d. – 1, 5
Q27P jj wt wt, j – – – n.d. ,, – 1, 2, 4, 5, 6
Q27R jj wt wt – – – n.d. ,, n.d. 4, 6
L28A jj wt wt ,, ,, , n.d. n.d. n.d. 1
L28A n.d. n.d. wt n.d. n.d. – n.d. n.d. – 5
L28R n.d. n.d. wt n.d. n.d. ,, n.d. n.d. – 5
L28G n.d. n.d. wt n.d. n.d. – n.d. n.d. – 5
L28P n.d. n.d. wt n.d. n.d. – n.d. n.d. – 5
DL28 n.d. n.d. wt n.d. n.d. – n.d. n.d. – 5
T29A wt wt , – – – n.d. n.d. n.d. 1
T29P n.d. n.d. wt n.d. n.d. – n.d. n.d. – 5
D30A ,,, wt , ,, – – – n.d. n.d. n.d. 1, 2
D30P n.d. n.d. j n.d. n.d. – n.d. n.d. – 5
P31A wt , wt ,, wt wt n.d. n.d. n.d. 1
P32A wt j wt , wt wt n.d. n.d. n.d. 1
R36A ,, , n.d. – – n.d. n.d. n.d. n.d. 2
V37A ,, wt n.d. ,, wt n.d. n.d. n.d. n.d. 2
Y38A – ,, n.d. – , n.d. n.d. n.d. n.d. 2
Y38C – – n.d. ,, wt n.d. n.d. n.d. n.d. 2
Y38F wt wt n.d. ,, wt n.d. n.d. n.d. n.d. 2
H39A ,, wt n.d. wt wt n.d. n.d. n.d. n.d. 2
G43P n.d. n.d. wt n.d. n.d. – n.d. n.d. – 5
Q132A wt j n.d. , wt n.d. n.d. n.d. n.d. 2
Q132P n.d. n.d. wt n.d. n.d. ,, n.d. n.d. – 5
R134A – wt n.d. , wt n.d. n.d. n.d. n.d. 2
K190P n.d. n.d. , n.d. n.d. ,, n.d. n.d. – 5
T213A , j n.d. wt wt n.d. n.d. n.d. n.d. 2
D215A – wt n.d. , wt n.d. n.d. n.d. n.d. 2
D215G ,, , jj , wt jj wt wt n.d. 3
S216A , wt n.d. wt wt n.d. n.d. n.d. n.d. 2
G218A ,, wt n.d. , wt n.d. n.d. n.d. n.d. 2
L220A ,, wt n.d. wt wt n.d. n.d. n.d. n.d. 2
P221A – wt n.d. wt wt n.d. n.d. n.d. n.d. 2
R222A , wt n.d. wt , n.d. n.d. n.d. n.d. 2
F223A wt wt n.d. j wt n.d. n.d. n.d. n.d. 2
A3C/Y38C – – – j wt , n.d. n.d. 2
Q132L/D215G – , j wt wt jj wt wt n.d. 3
S140N/D215G ,, , j j wt j wt wt n.d. 3
D215G/R222N – ,, , , wt j j wt n.d. 3
D215G/F223I – ,, , j , wt j j n.d. 3
R222N/F223I – ,, , j wt jj j jj n.d. 3
D215G/R222N/F223I ,, – – j wt j j j n.d. 3
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viral entry via HVEM also impaired viral entry via 3-O-S HS
(Yoon and Spear, 2004). (iii) Deletions of amino acids within
the HVEM contact regions (aa 7–32) in HSV-1 gD abrogated
physical and functional interactions with HVEM and 3-O-S HS
but were without effect on these interactions with nectin-1
(Yoon et al., 2003).
These results, taken together, demonstrate the critical
importance of the N-terminal domain of HSV-1 gD for
functional binding to HVEM and 3-O-S HS and the
irrelevance of this domain for functional binding to nectin-
1. Since the N-terminus was partially disordered and extended
in the structure obtained for gD crystallized alone, it seems
likely that interaction of gD with HVEM may stabilize the N-
terminal hairpin that is observed in the gD–HVEM co-
crystals. It should be noted that aa L25 and Q27, which are
critical for binding to HVEM, are also key residues mediating
the N-terminal/C-terminal contacts within gD that were
described in the preceding section. These observations could
explain the enhanced affinity of gD for HVEM when the C-
terminus of the ectodomain is truncated and the failure of
GST fusion proteins containing membrane-proximal gD
sequences to bind to truncated gD when HVEM is present.
It remains to be determined how amino acid substitutions
(G43P, Q132P, K190P) in gD that are outside the known
contacts with HVEM influence the conformation of gD and
its ability to bind to HVEM. It also remains to be determined
how 3-O-S HS binds to gD, what conformation gD assumes
in complex with 3-O-S HS, and why the mutations that
abrogate functional binding to HVEM also impair functional
interactions with 3-O-S HS.
The sequences of HSV-1 and HSV-2 gD are conserved
throughout the HVEM contact region except at position 7 where
the residues are A and P, respectively. Deletions of the HVEM
contact regions in HSV-1 and HSV-2 gDs have similar effects:
abrogation of functional interactions with HVEM without any
effect on interactions with nectin-1 (Yoon et al., 2003). There is
one difference in that such deletions also abrogate functional
interactions of HSV-2 gD with nectin-2, which is not usually a
functional receptor for HSV-1. In addition, the amino acid
sequence of the N-terminus determines whether nectin-2 can be
a functional entry and fusion receptor. Mutations L25P, Q27A,
Q27P, Q27R and L28A in HSV-1 gD confer entry and fusion
activity with nectin-2 (Connolly et al., 2003; Lopez et al., 2000;
Warner et al., 1998; Yoon et al., 2003). Also, the differences
between HSV-1 and HSV-2 gDs at 7 positions within the first 53
aa are responsible for the ability of wild-type HSV-2, but not
wild-type HSV-1 gD, to use nectin-2 as an entry/fusion receptor
(Zago and Spear, 2003). The primary interface on gD for nectin-
1 (and probably for the related nectin-2) is downstream of 32 aa,
based on the deletional analysis mentioned above. Nevertheless,
the presence and sequence of the N-terminus influence gD
interactions with nectin-2 but not nectin-1. We propose that a
secondary interface in the N-terminus may be important for
functional activity with nectin-2, but not nectin-1, or that the N-
terminus influences the conformation of the primary interface in
ways that are critical for nectin-2 but not nectin-1.Mutations that abrogate interactions of gD with nectins
A number of mutations have been introduced into gD
downstream of the N-terminus to identify residues critical for
functional interactions with nectin-1 (Figs. 1B and D). Double
or triple amino acid substitutions at positions located down-
stream of the Ig fold in HSV-1 or HSV-2 gD (D215G, R222N,
F223I) abrogated physical and functional interactions with
nectin-1 and nectin-2 but were without effect on interactions
with HVEM or 3-O-S HS or actually enhanced binding and
functional interactions with the latter two receptors (Manoj et
al., 2004). Substitution Y38C and the double mutation A3C/
Y38C (designed to permit formation of a disulfide bond to lock
the N-terminal hairpin conformation) in HSV-1 gD also
reduced physical and functional interactions with nectin-1 but
not with HVEM (Connolly et al., 2005). In the structure of gD
crystallized alone, these 4 residues (Y38, D215, R222 and
F223) are exposed on a surface that could interface with nectin-
1 and nectin-2 (Fig. 1D). In the structure of gD co-crystallized
with HVEM, this surface is partially occluded by the N-
terminal hairpin (Fig. 1C) and would not be accessible for
nectin binding. This suggests that gD can assume at least two
conformations in complexes with receptors, one capable of
binding to HVEM and characterized by an N-terminal hairpin
and another capable of binding to the nectins and characterized
by a different, as yet undefined, extended conformation of the
N-terminus.
Although distinct and different regions of gD were
identified as critical for physical and functional interactions
with HVEM and 3-O-HS, on the one hand, and nectins, on the
other, it should be noted that efficient binding of soluble
truncated forms of gD to HVEM or nectin-1 requires at least
the first 240–250 aa (Whitbeck et al., 1999). Also, efficient
binding of soluble HVEM:Fc or nectin-1:Fc to full-length
membrane-bound gD requires at least the first 261 aa of gD, as
determined from studies with chimeric gDs that are described
more fully below. Thus, the binding domains for HVEM and
nectin-1 cannot be physically separated on distinct fragments
of gD.
A region of gD required for cell fusion but not for receptor
binding
Studies with soluble truncated forms of HSV-1 gD and with
chimeric forms have shown that receptor-binding, which
requires the first 240–260 aa of gD depending on the assay,
is not sufficient for gD to trigger membrane fusion, either as
assessed by cell fusion or by viral entry. The results indicate
that the C-terminal membrane-proximal region of the gD
ectodomain, but not the membrane-spanning region (TM) or
cytoplasmic tail, has a role in membrane fusion distinct from
that of receptor binding. This membrane-proximal region of gD
includes the region that is believed to interact with the N-
terminus when receptor is not bound, as described above.
Evidence of a role for the C-terminus of the gD ectodomain
in triggering membrane fusion includes the following.
(i) Soluble truncated forms of HSV-1 gD were shown to
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but only if at least the first 290 aa of the ectodomain were
present for viral entry into baby hamster kidney cells, which
did not express human receptors, or at least 285 aa in the case
of cells over-expressing human nectin-1 (Cocchi et al., 2004).
Other forms of truncated gD comprising the first 250, 260 or
275 aa were fully capable of binding to nectin-1 and HVEM
(Whitbeck et al., 1999) but were deficient in promoting viral
entry (Cocchi et al., 2004). (ii) A chimeric membrane-bound
form of gD consisting of the first 260 aa of HSV-1 gD fused to
the C-terminus of CD8, 52 aa upstream from its TM, was not
functional in cell fusion assays (performed by co-transfection
of plasmids expressing gB, gH, gL and the gD/CD8 chimera),
whereas another chimera consisting of the first 315 aa of gD
fused to CD8 just upstream of its TM was functional (Cocchi
et al., 2004). (iii) Membrane-bound chimeras formed by
structure-guided swapping of sequences between HSV-1 gD
and pseudorabies virus (PRV) gD were capable of binding to
soluble forms of nectin-1 and HVEM, provided the first 261
aa were derived from HSV-1 gD. However, a chimera with the
first 261 aa from HSV-1 gD was not functional in cell fusion
assays. At least 285 aa from HSV-1 gD had to be present in
chimeras for cell fusion activity to be observed after
transfection of cells with plasmids expressing HSV-1 gB, gH
and gL along with the chimera (Zago et al., 2004). Consistent
with the findings summarized in points (i) and (ii) above, these
results define a region in HSV-1 gD, between aa 262 and 285,
that is required for cell fusion activity but not for receptor
binding. They also demonstrate that the equivalent region in
PRV gD cannot supply the activity required for cell fusion,
consistent with the fact that the full-length PRV gD cannot
substitute for HSV-1 gD in cell fusion assays using HSV-1
forms of gB, gH and gL. Human nectin-1, but not HVEM, is a
functional entry receptor for PRV (Geraghty et al., 1998;
Montgomery et al., 1996), and chimeras in which at least the
first 241 aa were derived from PRV gD were capable of
binding to nectin-1 but not to HVEM. These chimeras were
not active in cell fusion assays employing HSV-1 gB, gH and
gL, and nectin-1 as the fusion receptor, even though they
could engage a fusion receptor and the regions downstream of
aa 241, 261 or 285 were derived from HSV-1 gD (Zago et al.,
2004). (iv) Ten amino acid deletions in HSV-1 gD encom-
passing the region from 260–290 aa had little or no effect on
cell fusion activity, suggesting that no specific sequence or
length is required (Zago et al., 2004).
The data summarized above indicate that, in the absence of
receptor, a region of the gD ectodomain within aa 260–310
(particularly the most membrane-proximal part of this region)
can interact with another region in the receptor-binding domain
of gD (the contacts observed in an X-ray structure between
L25-Q27 and N293-W294 may account in part for this
interaction) to form a closed structure with the N-terminus of
gD folded down toward a membrane-proximal stalk. There
seem to be no specific sequence requirements for the region
between 260 and 290 aa, and 10-aa portions can be deleted
without effect on cell fusion, suggesting that much of this
region may be important for flexibility, to permit the foldingback of the N-terminus to the membrane-proximal region.
There must be some sequence or structural requirements within
the membrane-proximal region, however, perhaps mostly in the
region from aa 290–316, because the equivalent region from
PRV gD cannot substitute.
The proposed closed conformation of gD (Cocchi et al.,
2004) is almost certainly different from either conformation
that gD assumes when bound to HVEM or nectin-1. The
contacts required for the closed conformation apparently
cannot occur when receptor is present, given that the GST–
fusion proteins containing regions from aa 260–310 cannot
bind to the receptor-binding domain of gD when either
nectin-1 or HVEM is present (Fusco et al., 2005). Also, it
should be noted that contacts between L25-Q27 and HVEM
are essential for HVEM binding, and such contacts would
preclude interactions between L25-Q27 and N293-W294.
Also, assuming that the gD mutations shown to abrogate
nectin-1 binding (Figs. 1B and D) define an interface for this
receptor, nectin-1 binding would not permit the conformation
observed in the X-ray structure of the dimerized 306-aa form
of gD. These considerations lead to the hypothesis that
receptor binding converts the closed conformation of gD to
one of at least two different open conformations, one
constrained by the binding of HVEM and another by the
binding of nectin-1. In either case, it seems likely that the
change in gD conformation on receptor binding results in
interactions of gD with gB and/or gH–gL that activate
membrane-fusing activity.
Summary
Recent progress on defining the structure of gD in relation
to its function demonstrates the plasticity of gD conformation
even if all details of the variant conformations are not yet
understood. The results provide clues as to how receptor
interactions with gD might trigger HSV fusogenic activity,
which is probably mediated principally by gB and/or gH–gL.
Much remains to be learned, however, about the details of the
molecular events leading from receptor binding to membrane
fusion. Viral mutants expressing forms of gD that are restricted
to usage of a subset of all HSV entry receptors are now
available, or can be generated, and will prove to be invaluable
for determining which receptors are critical for infection of
specific differentiated cells types and for various aspects of
viral pathogenesis in experimental animals.
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